We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
PRAME
  • premium

    TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

PRAME

Gene description

Preferentially expressed antigen in melanoma

Protein class

Plasma proteins
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

10
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Group enriched (endometrial cancer, melanoma, ovarian cancer, testis cancer)
HPA (cell line):Cell line enhanced (K-562, SH-SY5Y)
HPA (normal tissue):Group enriched (epididymis, testis)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Granular cytoplasmic expression in seminiferous ducts in testis.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining consistent with RNA expression data. Pending external verification.

Reliability score

Supported based on 1 antibody.
HPA045153
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in renal cancer (unfavourable) and head and neck cancer (unfavourable).
Renal cancer p<0.001
Head and neck cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Group enriched (endometrial cancer, melanoma, ovarian cancer, testis cancer)

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer

STAINING SUMMARY

HPA045153

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Moderate cytoplasmic positivity was observed in few cases of melanoma. Weak to moderate membranous staining was displayed mainly in colorectal cancer. Weak cytoplasmic positivity was detected in few cases of other cancer types.

GENE INFORMATION

Gene name

PRAME (HGNC Symbol)

Synonyms

CT130, MAPE

Description

Preferentially expressed antigen in melanoma (HGNC Symbol)

Entrez gene summary

This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]

Chromosome

22

Cytoband

q11.22

Chromosome location (bp)

22547701 - 22559361

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000185686 (version 83.38)

Entrez gene

23532

UniProt

P78395 (UniProt - Evidence at protein level)

neXtProt

NX_P78395

Antibodypedia

PRAME antibodies

PROTEIN BROWSER

PRAME-001
PRAME-003
PRAME-004
PRAME-005
PRAME-006
PRAME-008
PRAME-009
PRAME-012
PRAME-201
PRAME-202

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

PRAME-001
ENSP00000381728
ENST00000398743
P78395 [Direct mapping]
Melanoma antigen preferentially expressed in tumors
A0A024R1E6 [Target identity:100%; Query identity:100%]
Preferentially expressed antigen in melanoma, isoform CRA_a
Show all
Predicted intracellular proteins
Plasma proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005886 [plasma membrane]
GO:0006351 [transcription, DNA-templated]
GO:0006915 [apoptotic process]
GO:0008284 [positive regulation of cell proliferation]
GO:0030154 [cell differentiation]
GO:0040008 [regulation of growth]
GO:0042974 [retinoic acid receptor binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0045596 [negative regulation of cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0048387 [negative regulation of retinoic acid receptor signaling pathway]
Show all
509 aa
57.9 kDa
No 0
PRAME-003
ENSP00000385198
ENST00000402697
P78395 [Direct mapping]
Melanoma antigen preferentially expressed in tumors
A0A024R1E6 [Target identity:100%; Query identity:100%]
Preferentially expressed antigen in melanoma, isoform CRA_a
Show all
Predicted intracellular proteins
Plasma proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005886 [plasma membrane]
GO:0006351 [transcription, DNA-templated]
GO:0006915 [apoptotic process]
GO:0008284 [positive regulation of cell proliferation]
GO:0030154 [cell differentiation]
GO:0040008 [regulation of growth]
GO:0042974 [retinoic acid receptor binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0045596 [negative regulation of cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0048387 [negative regulation of retinoic acid receptor signaling pathway]
Show all
509 aa
57.9 kDa
No 0
PRAME-004
ENSP00000384343
ENST00000405655
P78395 [Direct mapping]
Melanoma antigen preferentially expressed in tumors
A0A024R1E6 [Target identity:100%; Query identity:100%]
Preferentially expressed antigen in melanoma, isoform CRA_a
Show all
Predicted intracellular proteins
Plasma proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005886 [plasma membrane]
GO:0006351 [transcription, DNA-templated]
GO:0006915 [apoptotic process]
GO:0008284 [positive regulation of cell proliferation]
GO:0030154 [cell differentiation]
GO:0040008 [regulation of growth]
GO:0042974 [retinoic acid receptor binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0045596 [negative regulation of cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0048387 [negative regulation of retinoic acid receptor signaling pathway]
Show all
509 aa
57.9 kDa
No 0
PRAME-005
ENSP00000407320
ENST00000439106
E7EW99 [Direct mapping]
Melanoma antigen preferentially-expressed in tumors
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
201 aa
23.1 kDa
No 0
PRAME-006
ENSP00000384058
ENST00000406503
B5MCY4 [Direct mapping]
Melanoma antigen preferentially-expressed in tumors
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
115 aa
13.1 kDa
No 0
PRAME-008
ENSP00000412318
ENST00000420709
E7EMH2 [Direct mapping]
Melanoma antigen preferentially-expressed in tumors
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
152 aa
17.5 kDa
No 0
PRAME-009
ENSP00000385091
ENST00000403441
B5MD04 [Direct mapping]
Melanoma antigen preferentially-expressed in tumors
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
86 aa
9.8 kDa
No 0
PRAME-012
ENSP00000407121
ENST00000438888
H7C2P3 [Direct mapping]
Melanoma antigen preferentially-expressed in tumors
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
189 aa
21.1 kDa
No 0
PRAME-201
ENSP00000381726
ENST00000398741
P78395 [Direct mapping]
Melanoma antigen preferentially expressed in tumors
A0A024R1E6 [Target identity:100%; Query identity:100%]
Preferentially expressed antigen in melanoma, isoform CRA_a
Show all
Predicted intracellular proteins
Plasma proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005886 [plasma membrane]
GO:0006351 [transcription, DNA-templated]
GO:0006915 [apoptotic process]
GO:0008284 [positive regulation of cell proliferation]
GO:0030154 [cell differentiation]
GO:0040008 [regulation of growth]
GO:0042974 [retinoic acid receptor binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0045596 [negative regulation of cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0048387 [negative regulation of retinoic acid receptor signaling pathway]
Show all
509 aa
57.9 kDa
No 0
PRAME-202
ENSP00000445675
ENST00000543184
P78395 [Direct mapping]
Melanoma antigen preferentially expressed in tumors
A0A024R1E6 [Target identity:100%; Query identity:100%]
Preferentially expressed antigen in melanoma, isoform CRA_a
Show all
Predicted intracellular proteins
Plasma proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005886 [plasma membrane]
GO:0006351 [transcription, DNA-templated]
GO:0006915 [apoptotic process]
GO:0008284 [positive regulation of cell proliferation]
GO:0030154 [cell differentiation]
GO:0040008 [regulation of growth]
GO:0042974 [retinoic acid receptor binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0045596 [negative regulation of cell differentiation]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0048387 [negative regulation of retinoic acid receptor signaling pathway]
Show all
509 aa
57.9 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.